Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1998 Feb;82(2):146–149. doi: 10.1136/bjo.82.2.146

Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma

P Diggory 1, A Cassels-Brown 1, A Vail 1, J Hillman 1
PMCID: PMC1722479  PMID: 9613379

Abstract

AIM—To investigate respiratory and cardiovascular side effects in elderly people in the first 12 months after commencing topical β antagonists.
METHODS—40 patients (mean age 74 years) were recruited to a randomised, masked study. Spirometry, pulse, and blood pressure were recorded before, 1 month, and 12 months after starting topical therapy with either timolol 0.5% twice daily or betaxolol 0.5% twice daily.
RESULTS—After 1 month five of 20 patients allocated timolol and three of 20 given betaxolol had discontinued it for respiratory reasons, not always accompanied by symptoms. There were no significant differences in changes in mean values of spirometry, pulse, or blood pressure between groups. No further changes were made in therapy for respiratory reasons in the following year. One patient suffered a hypotensive stroke within 2 days of starting timolol.
CONCLUSIONS—By performing spirometry before starting topical β antagonist therapy and repeating it after 1 month most patients at risk of respiratory impairment can be identified.

 Keywords: spirometry; elderly; timolol; betaxolol; glaucoma

Full Text

The Full Text of this article is available as a PDF (111.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banerjee D. K., Lee G. S., Malik S. K., Daly S. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987 Jan;81(1):23–29. doi: 10.1016/0007-0971(87)90104-5. [DOI] [PubMed] [Google Scholar]
  2. Berrospi A. R., Leibowitz H. M. Betaxolol. A new beta-adrenergic blocking agent for treatment of glaucoma. Arch Ophthalmol. 1982 Jun;100(6):943–946. doi: 10.1001/archopht.1982.01030030951011. [DOI] [PubMed] [Google Scholar]
  3. Bodner C., Ross S., Douglas G., Little J., Legge J., Friend J., Godden D. The prevalence of adult onset wheeze: longitudinal study. BMJ. 1997 Mar 15;314(7083):792–793. doi: 10.1136/bmj.314.7083.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chowienczyk P. J., Lawson C. P. Pocket-sized device for measuring forced expiratory volume in one second and forced vital capacity. Br Med J (Clin Res Ed) 1982 Jul 3;285(6334):15–17. doi: 10.1136/bmj.285.6334.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Connolly M. J., Crowley J. J., Charan N. B., Nielson C. P., Vestal R. E. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992 Jun;47(6):410–413. doi: 10.1136/thx.47.6.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diggory P., Cassels-Brown A., Vail A., Abbey L. M., Hillman J. S. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet. 1995 Jun 24;345(8965):1604–1606. doi: 10.1016/s0140-6736(95)90116-7. [DOI] [PubMed] [Google Scholar]
  7. Dodge R. R., Burrows B. The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis. 1980 Oct;122(4):567–575. doi: 10.1164/arrd.1980.122.4.567. [DOI] [PubMed] [Google Scholar]
  8. Fraunfelder F. T., Meyer S. M. Systemic side effects from ophthalmic timolol and their prevention. J Ocul Pharmacol. 1987 Summer;3(2):177–184. doi: 10.1089/jop.1987.3.177. [DOI] [PubMed] [Google Scholar]
  9. Hodkinson H. M. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233–238. doi: 10.1093/ageing/1.4.233. [DOI] [PubMed] [Google Scholar]
  10. Klein B. E., Klein R., Sponsel W. E., Franke T., Cantor L. B., Martone J., Menage M. J. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992 Oct;99(10):1499–1504. doi: 10.1016/s0161-6420(92)31774-9. [DOI] [PubMed] [Google Scholar]
  11. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  12. Renwick D. S., Connolly M. J. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax. 1996 Feb;51(2):164–168. doi: 10.1136/thx.51.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Zimmerman T. J., Kaufman H. E. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol. 1977 Apr;95(4):601–604. doi: 10.1001/archopht.1977.04450040067008. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES